A detailed history of Dn B Asset Management As transactions in Geron Corp stock. As of the latest transaction made, Dn B Asset Management As holds 136,581 shares of GERN stock, worth $207,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,581
Previous 92,243 48.07%
Holding current value
$207,603
Previous $326,000 33.44%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.59 - $3.6 $70,497 - $159,616
44,338 Added 48.07%
136,581 $217,000
Q4 2024

Feb 12, 2025

BUY
$3.3 - $4.44 $44,860 - $60,357
13,594 Added 17.28%
92,243 $326,000
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $327,966 - $392,458
78,649 New
78,649 $357,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $574M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.